Literature DB >> 24641623

Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.

Zhican Wang1, Timothy Wong, Takanori Hashizume, Leslie Z Dickmann, Michele Scian, Nicholas J Koszewski, Jesse P Goff, Ronald L Horst, Amarjit S Chaudhry, Erin G Schuetz, Kenneth E Thummel.   

Abstract

25-Hydroxyvitamin D3 (25OHD3) is used as a clinical biomarker for assessment of vitamin D status. Blood levels of 25OHD3 represent a balance between its formation rate and clearance by several oxidative and conjugative processes. In the present study, the identity of human uridine 5'-diphosphoglucuronyltransferases (UGTs) capable of catalyzing the 25OHD3 glucuronidation reaction was investigated. Two isozymes, UGT1A4 and UGT1A3, were identified as the principal catalysts of 25OHD3 glucuronidation in human liver. Three 25OHD3 monoglucuronides (25OHD3-25-glucuronide, 25OHD3-3-glucuronide, and 5,6-trans-25OHD3-25-glucuronide) were generated by recombinant UGT1A4/UGT1A3, human liver microsomes, and human hepatocytes. The kinetics of 25OHD3 glucuronide formation in all systems tested conformed to the Michaelis-Menten model. An association between the UGT1A4*3 (Leu48Val) gene polymorphism with the rates of glucuronide formation was also investigated using human liver microsomes isolated from 80 genotyped livers. A variant allele dose effect was observed: the homozygous UGT1A4*3 livers (GG) had the highest glucuronidation activity, whereas the wild type (TT) had the lowest activity. Induction of UGT1A4 and UGT1A3 gene expression was also determined in human hepatocytes treated with pregnane X receptor/constitutive androstane receptor agonists, such as rifampin, carbamazepine, and phenobarbital. Although UGT mRNA levels were increased significantly by all of the known pregnane X receptor/constitutive androstane receptor agonists tested, rifampin, the most potent of the inducers, significantly induced total 25OHD3 glucuronide formation activity in human hepatocytes measured after 2, but not 4 and 24 hours, of incubation. Finally, the presence of 25OHD3-3-glucuronide in both human plasma and bile was confirmed, suggesting that the glucuronidation pathway might be physiologically relevant and contribute to vitamin D homeostasis in humans.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24641623      PMCID: PMC4020929          DOI: 10.1210/en.2013-2013

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  41 in total

Review 1.  Cytochrome P450-mediated metabolism of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  J Lipid Res       Date:  2013-04-06       Impact factor: 5.922

2.  In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

Authors:  M B Fisher; K Campanale; B L Ackermann; M VandenBranden; S A Wrighton
Journal:  Drug Metab Dispos       Date:  2000-05       Impact factor: 3.922

3.  Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals.

Authors:  R L Horst; E T Littledike; J L Riley; J L Napoli
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

4.  The isolation and identification of 5,6-trans-25-hydroxyvitamin D3 from the plasma of rats dosed with vitamin D3. Evidence for a novel mechanism in the metabolism of vitamin D3.

Authors:  R Kumar; S Nagubandi; I Jardine; J M Londowski; S Bollman
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

5.  25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man.

Authors:  S B Arnaud; R S Goldsmith; P W Lambert; V L Go
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

6.  Lamotrigine clearance during pregnancy.

Authors:  T A Tran; I E Leppik; K Blesi; S T Sathanandan; R Remmel
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

7.  Characterization of urinary metabolites of vitamin D(3) in man under physiological conditions using liquid chromatography-tandem mass spectrometry.

Authors:  Tatsuya Higashi; Satomi Homma; Haruko Iwata; Kazutake Shimada
Journal:  J Pharm Biomed Anal       Date:  2002-07-31       Impact factor: 3.935

Review 8.  Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches.

Authors:  John O Miners; Paul A Smith; Michael J Sorich; Ross A McKinnon; Peter I Mackenzie
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

Review 9.  Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase.

Authors:  Martin Hewison; Daniel Zehnder; Ronjon Chakraverty; John S Adams
Journal:  Mol Cell Endocrinol       Date:  2004-02-27       Impact factor: 4.102

10.  Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

Authors:  Yvonne S Lin; Amy L S Dowling; Sean D Quigley; Federico M Farin; Jiong Zhang; Jatinder Lamba; Erin G Schuetz; Kenneth E Thummel
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

View more
  18 in total

1.  Ganoderic acid B's influence towards the therapeutic window of trifluoperazine (TFP).

Authors:  Jun Guo; Chenming Ni; Xiaoyang Liu; Tao Liu
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

2.  Localization of the 1,25-dihydroxyvitamin d-mediated response in the intestines of mice.

Authors:  Carmen J Reynolds; Nicholas J Koszewski; Ronald L Horst; Donald C Beitz; Jesse P Goff
Journal:  J Steroid Biochem Mol Biol       Date:  2018-09-17       Impact factor: 4.292

3.  Simultaneous quantification of 25-hydroxyvitamin D3-3-sulfate and 25-hydroxyvitamin D3-3-glucuronide in human serum and plasma using liquid chromatography-tandem mass spectrometry coupled with DAPTAD-derivatization.

Authors:  Chunying Gao; Mackenzie C Bergagnini-Kolev; Michael Z Liao; Zhican Wang; Timothy Wong; Justina C Calamia; Yvonne S Lin; Qingcheng Mao; Kenneth E Thummel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-06-09       Impact factor: 3.205

Review 4.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

Review 5.  Vitamin D Metabolism and Guidelines for Vitamin D Supplementation.

Authors:  Indra Ramasamy
Journal:  Clin Biochem Rev       Date:  2020-12

6.  A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug-Drug Interactions.

Authors:  Todd M Conner; Ronald C Reed; Tao Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-06       Impact factor: 2.441

7.  Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract.

Authors:  Chunying Gao; Michael Z Liao; Lyrialle W Han; Kenneth E Thummel; Qingcheng Mao
Journal:  Drug Metab Dispos       Date:  2018-02-21       Impact factor: 3.922

8.  Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D3-3-O-Sulfate, a Major Circulating Vitamin D Metabolite in Humans.

Authors:  Timothy Wong; Zhican Wang; Brian D Chapron; Mizuki Suzuki; Katrina G Claw; Chunying Gao; Robert S Foti; Bhagwat Prasad; Alenka Chapron; Justina Calamia; Amarjit Chaudhry; Erin G Schuetz; Ronald L Horst; Qingcheng Mao; Ian H de Boer; Timothy A Thornton; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2018-01-17       Impact factor: 3.922

9.  Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.

Authors:  Todd M Conner; Vahagn C Nikolian; Patrick E Georgoff; Manjunath P Pai; Hasan B Alam; Duxin Sun; Ronald C Reed; Tao Zhang
Journal:  Eur J Pharm Sci       Date:  2017-10-10       Impact factor: 4.384

10.  Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by Cyp24a1 and Cyp3a using Cyp24a1 knockout rats generated by CRISPR/Cas9 system.

Authors:  Kaori Yasuda; Miyu Nishikawa; Kairi Okamoto; Kyohei Horibe; Hiroki Mano; Mana Yamaguchi; Risa Okon; Kimie Nakagawa; Naoko Tsugawa; Toshio Okano; Fumihiro Kawagoe; Atsushi Kittaka; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  J Biol Chem       Date:  2021-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.